Results 71 to 80 of about 2,974,682 (398)

Phosphodiesterase III inhibitor promotes drainage of cerebrovascular β-amyloid

open access: yesAnnals of Clinical and Translational Neurology, 2014
Brain amyloidosis is a key feature of Alzheimer's disease (AD). It also incorporates cerebrovascular amyloid β (Aβ) in the form of cerebral amyloid angiopathy (CAA) involving neurovascular dysfunction.
Takakuni Maki   +16 more
semanticscholar   +1 more source

Protein Language Model‐Guided Engineering of a 2,3‐Butanediol Dehydrogenase for the Enantioselective Synthesis of Cyclic α‐Hydroxy Ketones

open access: yesAdvanced Science, EarlyView.
A (2R,3R)‐butanediol dehydrogenase from Bacillus subtilis (BsBDH) is engineered for the enantioselective synthesis of 2‐hydroxycyclohexanone. A PASS computational design strategy is proposed to enhance the thermostability of BsBDH. Moreover, ESM‐1v combined with ISM is utilized for enhancing and inverting its stereoselectivity.
Haote Ding   +5 more
wiley   +1 more source

Role of phosphodiesterase in glucagon resistance of large adipocytes

open access: yesJournal of Lipid Research, 1974
The role of phosphodiesterase in glucagon resistance of large adipocytes was investigated. A comparison was made of phosphodiesterase activities of homogenates prepared from isolated small (mean diameter ≃ 45 μm) and large (mean diameter ≃ 78 μm ...
Richard A. De Santis   +3 more
doaj   +1 more source

Nonsteroidal anti-inflammatory drugs as potential ecto-nucleotide phosphodiesterase inhibitors

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2020
Phosphodiesterases (PDE) are group of enzymes which catalyze the hydrolysis of cAMP and cGMP. Since these cyclic phosphate moieties worked as intracellular second messengers in numerous physiological processes, their inhibition can affect normal ...
Shumaila Tasneem   +2 more
doaj   +1 more source

Discovery of a Phosphodiesterase 9A Inhibitor as a Potential Hypoglycemic Agent

open access: yesJournal of Medicinal Chemistry, 2014
Phosphodiesterase 9 (PDE9) inhibitors have been studied as potential therapeutics for treatment of diabetes and Alzheimer’s disease. Here we report a potent PDE9 inhibitor 3r that has an IC50 of 0.6 nM and >150-fold selectivity over other PDEs. The HepG2
Yong-Xian Shao   +11 more
semanticscholar   +1 more source

Decoding Human Placental Cellular and Molecular Responses to Obesity and Fetal Growth

open access: yesAdvanced Science, EarlyView.
Women with obesity often deliver large‐for‐gestational‐age (LGA) infants. Single‐nucleus RNA sequencing of term placenta reveals that hypoxia and TNF‐α signaling in syncytiotrophoblasts are featured in maternal obesity, but inflammatory signatures in Hofbauer cells and response to lipid or carbohydrate metabolism in fibroblasts are specific to LGA.
Hong Jiang   +12 more
wiley   +1 more source

TDP2 promotes repair of topoisomerase I-mediated DNA damage in the absence of TDP1 [PDF]

open access: yes, 2012
The abortive activity of topoisomerases can result in clastogenic and/or lethal DNA damage in which the topoisomerase is covalently linked to the 3'- or 5'-terminus of a DNA strand break. This type of DNA damage is implicated in chromosome translocations
Abhishek Sharma   +36 more
core   +1 more source

Learned Conformational Space and Pharmacophore Into Molecular Foundational Model

open access: yesAdvanced Science, EarlyView.
The Ouroboros model introduces two orthogonal modules within a unified framework that independently learn molecular representations and generate chemical structures. This design enables flexible optimization strategies for each module and faithful structure reconstruction without prompts or noise.
Lin Wang   +8 more
wiley   +1 more source

RESOLUTION OF THE COUNCIL OF EXPERTS ON «THE PLACE OF PHOSPHODIESTERASE-4 INHIBITOR IN THE COMBINATION TREATMENT OF MODERATE TO SEVERE PSORIASIS AND ACTIVE PSORIATIC ARTHRITIS»

open access: yesНаучно-практическая ревматология, 2017
Resolution of the Council of Experts on «The place of phosphodiesterase-4 inhibitor in the combination treatment of moderate to severe psoriasis and active psoriatic arthritis».

doaj   +2 more sources

New in treatment of hyperactive bladder with urge urinary incontinence in women

open access: yesБюллетень сибирской медицины, 2012
The combination of α1 adrenoceptor blocking agent and phosphodiesterase  inhibitor of 5th type is efficient in treatment of women with hyperactive bladder and urge urinary incontinence, which was proved by the studies of urodynamic and microcirculation ...
A. I. Neimark   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy